Clinical Examination; Clinical History - Fscaresystems Viridex Rf Bedienungsanleitung

MANUEL
RF

medial saphenous vein

external saphenous vein

anterior crural saphenous vein

superficial circumflex iliac vein

saphenous vein medial accessory

The "lateral venous system under the dermis" described by Albanese .....
In difficult cases transillumination can be helpful.
Varicosities with cellulite
Cellulite, an inexhaustible subject in the popular press, is much less obtrusive in medical
publications. Its physiopathology and definition have long been a source of controversy.
Currently it seems reasonable to reserve the term cellulite exclusively for the disfigurement
that affects our contemporaries in a variety of ways.
This is a lipodystrophy, in other words an increase in the number or volume of adipocytes.
They are found in the superficial part of the hypodermis. Cellulite is dependent on vascular,
hormonal, genetic and nutritional factors. The vascular factor, i.e. stasis, leads to water
retention and contributes to maintaining and aggravating the cellulite.
On the contrary, adipocyte hypertrophy disrupts veno-lymphatic return and the compression
by external pressure of the superficial venous system creates upstream hyperpressure with
dilation of the microvenules and the appearance of varicosities. These varicosities are often
isolated.
3.7.

Clinical examination

It draws on the knowledge and experience of the doctor. It expresses the nobility of our art. It
is irreplaceable.
The aim of clinical examination is:

To assess the overall condition of the limb:

Physical examination of the leg: shape - appearance - oedema - varicose veins -
cellulite - signs of cutaneous distress.

To identify negative factors affecting venous return and to target those to be combatted.

3.7.1. Clinical History

Reasons for consultation
Aesthétic
90% of consultations.
The beauty of the legs is a major element of the feminine aesthetic and no phlebological lesion
is acceptable from an aesthetic point of view.
Prevention
Date 27/03/2014
THERMOCOAGULATION – Viridex
Page 26 de 49 N° de révision : 05